5Z-7R-10R-ETHYLISOXAZOLINADDUKTOXIRAN-3-OH
Compound with spectra: 2 NMR
| SpectraBase Compound ID | LTHo75ZkGvJ |
|---|---|
| InChI | InChI=1S/C30H49NO3/c1-6-23-19-29(34-31-23)16-13-24(32)17-22(29)18-27-30(33-27)15-8-14-28(5)25(11-12-26(28)30)21(4)10-7-9-20(2)3/h18,20-21,24-27,32H,6-17,19H2,1-5H3/b22-18+/t21?,24-,25-,26?,27-,28-,29?,30-/m0/s1 |
| InChIKey | ZXGAZBPALWYTGQ-ZXCKSOHDSA-N |
| Mol Weight | 471.7 g/mol |
| Molecular Formula | C30H49NO3 |
| Exact Mass | 471.371244 g/mol |
| Enantiomer InChIKey | ZXGAZBPALWYTGQ-MFDBUFODSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
- 5Z-7R-10S-ETHYLISOXAZOLINADDUKTOXIRAN-3-OH
2-Methyl-4-(4-hydroxybenzylidene)-1-{2-[N-[1-(isooct-2-yl)-2-(9a,11a-dimethylhexahydroindeno[4,5-a]naphth-2-yloxycarbomoyl)]ethyl]}imidazolin-5-one
N-(2-THIOETHYL)-3,7,12-TRIOXO-5-BETA-CHOLAN-24-AMIDE
(7S,8S,1'R,4'R,5'S)-4,4'-DIHYDROXY-3,3'-DIMETHOXY-6'-OXO-8.1',7.5'-NEOLIGNAN-DELTA
1,4a,6a-Trimethyl-2-oxo-2,3,4,4a,4b,5,6,6a,7,8,9,9a,9b,10-tetradecahydro-1H-indeno[5,4-f]quinolin-7-yl (4-[bis(2-chloroethyl)amino]phenyl)acetate
Cholan-24-oic acid, 3,7,12-trioxo-, methyl ester
(2R)-2-[(3S,8S,9S,10R,13S,14S,17S)-3-[tert-butyl(dimethyl)silyl]oxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-(1-methoxy-1-methyl-ethoxy)pent-3-yn-2-ol
ARCTOLIDE,DESACETYL,3-(2'-METHYL)-BUTYRYL
| Title | Journal or Book | Year |
|---|---|---|
| Über die Darstellung der 7R-Oxirane von 5Z- und 5E-10-Oxo-19-norcholecalciferol | Monatshefte für Chemie - Chemical Monthly | 1994 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.